stars 1 stars 2 stars 3

TissueGen solves for unmet needs through the development of transformative drug delivery technologies that reduce treatment burden and improve clinical outcomes. We create life changing treatment modalities for patients and their caregivers, treating both acute and chronic conditions.

TissueGen, Inc. Questions

The TissueGen, Inc. annual revenue was $9 million in 2026.

Kevin Nelson is the Chief Scientific Officer of TissueGen, Inc..

7 people are employed at TissueGen, Inc..

TissueGen, Inc. is based in Dallas, Texas.

The NAICS codes for TissueGen, Inc. are [32541, 325, 32, 3254].

The SIC codes for TissueGen, Inc. are [283, 28].

Top TissueGen, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users